SEC Filings | Enanta Pharmaceuticals, Inc.

SEC Filings

Filing date	Form	Description	Filing Group	View
Dec 09, 2013	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0000908662-13-000305.pdf 0000908662-13-000305.rtf 0000908662-13-000305.xls
Dec 09, 2013	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0000908662-13-000306.pdf 0000908662-13-000306.rtf 0000908662-13-000306.xls
Dec 09, 2013	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0000908662-13-000307.pdf 0000908662-13-000307.rtf 0000908662-13-000307.xls
Dec 06, 2013	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0000908662-13-000295.pdf 0000908662-13-000295.rtf 0000908662-13-000295.xls
Dec 06, 2013	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0000908662-13-000296.pdf 0000908662-13-000296.rtf 0000908662-13-000296.xls
Dec 06, 2013	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0000908662-13-000300.pdf 0000908662-13-000300.rtf 0000908662-13-000300.xls
Dec 06, 2013	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0000908662-13-000301.pdf 0000908662-13-000301.rtf 0000908662-13-000301.xls
Dec 06, 2013	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0000908662-13-000302.pdf 0000908662-13-000302.rtf 0000908662-13-000302.xls
Dec 06, 2013	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0000908662-13-000304.pdf 0000908662-13-000304.rtf 0000908662-13-000304.xls
Nov 27, 2013	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0000908662-13-000291.pdf 0000908662-13-000291.rtf 0000908662-13-000291.xls

Data provided by Kaleidoscope.

Print Page Print Page
Email Alerts Email Alerts
RSS Feeds RSS Feeds
Contact IR Contact IR